Advanced

The Swedish rectal cancer registry

Pahlman, L.; Bohe, Måns LU ; Cedermark, B.; Dahlberg, M.; Lindmark, G.; Sjodahl, R.; Ojerskog, B.; Damber, L. and Johansson, R. (2007) In British Journal of Surgery 94(10). p.1285-1292
Abstract
Background: An audit of all patients with rectal cancer in Sweden was launched in 1995. This is the first report from the Swedish Rectal Cancer Registry (SRCR). Methods: Between 1995 and 2003, 13 434 patients treated for adenocarcinoma of the rectum were registered with the SRCR; there were approximately 1500 new patients annually. Results: Approximately half had an anterior resection, a quarter an abdominoperineal resection and 15 per cent a Hartmann's procedure. The median 30-day postoperative mortality rate was 2.4 per cent and the overall postoperative morbidity rate was 35.0 per cent. The 5-year cancer-specific survival rate was 62.3 per cent. The 5-year relative survival rate was 70.1 per cent after anterior resection, 59.8 per cent... (More)
Background: An audit of all patients with rectal cancer in Sweden was launched in 1995. This is the first report from the Swedish Rectal Cancer Registry (SRCR). Methods: Between 1995 and 2003, 13 434 patients treated for adenocarcinoma of the rectum were registered with the SRCR; there were approximately 1500 new patients annually. Results: Approximately half had an anterior resection, a quarter an abdominoperineal resection and 15 per cent a Hartmann's procedure. The median 30-day postoperative mortality rate was 2.4 per cent and the overall postoperative morbidity rate was 35.0 per cent. The 5-year cancer-specific survival rate was 62.3 per cent. The 5-year relative survival rate was 70.1 per cent after anterior resection, 59.8 per cent after abdominoperineal resection and 39.8 per cent after a Hartmann's procedure. The crude 5-year local recurrence rate was 9.5 per cent overall, 6.1 per cent after preoperative radiotherapy and 11.4 per cent after surgery alone. For 3868 patients who had a locally curative procedure the local recurrence rate was 7.4 per cent overall, 5.9 per cent for those who had radiotherapy and 10.2 per cent for those who did not. The local recurrence rate was 2.9 percent (28 of 968) for stage I disease, 7.9 per cent (112 of 1418) for stage H, 13.9 per cent (188 of 1357) for stage III and 8.5 per cent (45 of 532) for stage IV. Conclusion: These good population-based results are due, in part, to the nationwide prospective quality assurance registration. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
British Journal of Surgery
volume
94
issue
10
pages
1285 - 1292
publisher
John Wiley & Sons
external identifiers
  • wos:000250210800017
  • scopus:35348816682
ISSN
1365-2168
DOI
10.1002/bjs.5679
language
English
LU publication?
yes
id
1965c829-d90e-4295-ae72-3e80080fabca (old id 655423)
date added to LUP
2007-12-17 09:28:47
date last changed
2017-11-12 03:29:59
@article{1965c829-d90e-4295-ae72-3e80080fabca,
  abstract     = {Background: An audit of all patients with rectal cancer in Sweden was launched in 1995. This is the first report from the Swedish Rectal Cancer Registry (SRCR). Methods: Between 1995 and 2003, 13 434 patients treated for adenocarcinoma of the rectum were registered with the SRCR; there were approximately 1500 new patients annually. Results: Approximately half had an anterior resection, a quarter an abdominoperineal resection and 15 per cent a Hartmann's procedure. The median 30-day postoperative mortality rate was 2.4 per cent and the overall postoperative morbidity rate was 35.0 per cent. The 5-year cancer-specific survival rate was 62.3 per cent. The 5-year relative survival rate was 70.1 per cent after anterior resection, 59.8 per cent after abdominoperineal resection and 39.8 per cent after a Hartmann's procedure. The crude 5-year local recurrence rate was 9.5 per cent overall, 6.1 per cent after preoperative radiotherapy and 11.4 per cent after surgery alone. For 3868 patients who had a locally curative procedure the local recurrence rate was 7.4 per cent overall, 5.9 per cent for those who had radiotherapy and 10.2 per cent for those who did not. The local recurrence rate was 2.9 percent (28 of 968) for stage I disease, 7.9 per cent (112 of 1418) for stage H, 13.9 per cent (188 of 1357) for stage III and 8.5 per cent (45 of 532) for stage IV. Conclusion: These good population-based results are due, in part, to the nationwide prospective quality assurance registration.},
  author       = {Pahlman, L. and Bohe, Måns and Cedermark, B. and Dahlberg, M. and Lindmark, G. and Sjodahl, R. and Ojerskog, B. and Damber, L. and Johansson, R.},
  issn         = {1365-2168},
  language     = {eng},
  number       = {10},
  pages        = {1285--1292},
  publisher    = {John Wiley & Sons},
  series       = {British Journal of Surgery},
  title        = {The Swedish rectal cancer registry},
  url          = {http://dx.doi.org/10.1002/bjs.5679},
  volume       = {94},
  year         = {2007},
}